Top Markets
#1 Zora Zora +36.32%
#2 AI XOVIA AI XOVIA +31.92%
#3 Full Moon Full Moon +19.37%
#4 Notcoin Notcoin +15.94%
#5 0G 0G +15.52%
#6 Axelar Axelar +12.94%
#7 Wrapped NXM Wrapped NXM +12.69%
#8 rsERG rsERG +12.06%
#9 Seeker Seeker +11.21%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +10.43%
Coin of the day
Zora Zora
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Classificação em ações #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Preço da ação
$11.03
Última sincronização: 2026-08-28
Valor de mercado
$597.15M
Variação (1 dia)
-4.25%
Variação (1 ano)
-
País
US
Negociar Eikon Therapeutics, Inc. Common Stock (EIKN)

Categoria

Healthcare
Receita da Eikon Therapeutics, Inc. Common Stock (EIKN)
Receita em Aug 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Eikon Therapeutics, Inc. Common Stock, a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Eikon Therapeutics, Inc. Common Stock de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH